synergy nash tirzepatide In the SYNERGY-NASH trial, researchers assessed the efficacy and safety of once Tirzepatide Shows Promise in Treating

Monitoring your heart rate is a critical step for anyone taking semaglutide

Tranexamic Acid Tranexamic Acid has gained popularity for melasma treatment

and a Novo Nordisk false advertising lawsuit filed August 2025

Rest and hydration are key to managing these symptoms

Patients with pre-existing conditions including cardiovascular disease, liver disease, thyroid disorders, kidney disease, or gallbladder disease face particular uncertainty

Lipid profile improvements (TRIUMPH-4): Non-HDL cholesterol: Clinically meaningful reduction Triglycerides: Significant reduction hsCRP (inflammatory marker): Significant reduction HDL cholesterol: Not significantly improved (consistent with Phase 2 findings) The triglyceride reduction is particularly notable and likely related to glucagon receptor activation, which enhances fat oxidation